DDAH1 and endothelial dysfunction: Since DDAH is the key enzyme of endogenous ADMA degradation, inhibition of vascular DDAH activity has been reported to be involved in diabetic endothelial dysfunction [10,34], and DDAH1 or DDAH2 knockout mice showed endothelial dysfunction or endogenous ADMA accumulation [35–36].